A Double-Blind Placebo Controlled Trial of Divalproex [valproate semisodium] and Olanzapine in Bipolar I Disorder, Mixed Episode.

Trial Profile

A Double-Blind Placebo Controlled Trial of Divalproex [valproate semisodium] and Olanzapine in Bipolar I Disorder, Mixed Episode.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2009

At a glance

  • Drugs Olanzapine; Valproate semisodium
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Nov 2009 Results published in the Journal of Clinical Psychiatry.
    • 02 Jun 2009 Actual patient number changed from 199 to 202 as reported by ClinicalTrials.gov.
    • 02 Jun 2009 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top